These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 15986394

  • 21. Screening for pulmonary arterial hypertension in patients with scleroderma--a New Zealand perspective.
    Ghosh SK, Corkill MM, Hart HH, Ng KP.
    N Z Med J; 2014 Aug 15; 127(1400):30-8. PubMed ID: 25145365
    [Abstract] [Full Text] [Related]

  • 22. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
    Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, Desai A, Seibold JR.
    J Rheumatol; 2008 Mar 15; 35(3):458-65. PubMed ID: 18203320
    [Abstract] [Full Text] [Related]

  • 23. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
    Hofstee HM, Vonk Noordegraaf A, Voskuyl AE, Dijkmans BA, Postmus PE, Smulders YM, Serné EH.
    Ann Rheum Dis; 2009 Feb 15; 68(2):191-5. PubMed ID: 18375538
    [Abstract] [Full Text] [Related]

  • 24. Pulmonary arterial hypertension in connective tissue diseases.
    Yoshida S.
    Allergol Int; 2011 Dec 15; 60(4):405-9. PubMed ID: 22015567
    [Abstract] [Full Text] [Related]

  • 25. The occurrence of pulmonary hypertension in patients with systemic sclerosis hospitalized in the Department of Rheumatology and Internal Diseases Medical University of Białystok in years 2003-2004.
    Gińdzieńska-Sieśkiewicz E, Kowal-Bielecka O, Kita J, Lisowska A, Domysławska I, Musiał W, Sierakowski S.
    Rocz Akad Med Bialymst; 2005 Dec 15; 50 Suppl 1():297-300. PubMed ID: 16119691
    [Abstract] [Full Text] [Related]

  • 26. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.
    Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L, Krishnan JA, Wigley F, Hassoun PM.
    Arthritis Rheum; 2006 Sep 15; 54(9):3043-50. PubMed ID: 16947776
    [Abstract] [Full Text] [Related]

  • 27. Tissue Doppler imaging study of right ventricular myocardial systolic activation in subjects with pulmonary arterial hypertension.
    You XD, Pu ZX, Peng XJ, Zheng SZ.
    Chin Med J (Engl); 2007 Jul 05; 120(13):1172-5. PubMed ID: 17637247
    [Abstract] [Full Text] [Related]

  • 28. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.
    Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin le TH, Cacoub P, Frances C, Wechsler B, Grenier P, Piette JC.
    Arthritis Rheum; 2006 Jan 05; 54(1):184-91. PubMed ID: 16385514
    [Abstract] [Full Text] [Related]

  • 29. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
    Cansu DÜ, Korkmaz C.
    Clin Rheumatol; 2023 Oct 05; 42(10):2601-2610. PubMed ID: 36396789
    [Abstract] [Full Text] [Related]

  • 30. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
    Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, Kahan A, Cabane J, Francès C, Launay D, Mouthon L, Allanore Y, Tiev KP, Clerson P, de Groote P, Humbert M.
    Arthritis Rheum; 2005 Dec 05; 52(12):3792-800. PubMed ID: 16320330
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of pulmonary hypertension in systemic sclerosis.
    de Azevedo AB, Sampaio-Barros PD, Torres RM, Moreira C.
    Clin Exp Rheumatol; 2005 Dec 05; 23(4):447-54. PubMed ID: 16095111
    [Abstract] [Full Text] [Related]

  • 32. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.
    Kampolis C, Plastiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G.
    Scand J Rheumatol; 2008 Dec 05; 37(4):278-83. PubMed ID: 18612928
    [Abstract] [Full Text] [Related]

  • 33. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
    Proudman SM, Stevens WM, Sahhar J, Celermajer D.
    Intern Med J; 2007 Jul 05; 37(7):485-94. PubMed ID: 17547726
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus.
    Prabu A, Patel K, Yee CS, Nightingale P, Situnayake RD, Thickett DR, Townend JN, Gordon C.
    Rheumatology (Oxford); 2009 Dec 05; 48(12):1506-11. PubMed ID: 19671698
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H, Steen V, Allanore Y, Saggar R, Saggar R, Maranian P, Berrocal VJ, Avouac J, Meune C, Trivedi M, Khanna D.
    J Rheumatol; 2013 Oct 05; 40(10):1706-11. PubMed ID: 23950183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.